Browsing: SABR

This analysis of the FASTRACK II trial quantified the dose-effect relationship of SABR on kidney function showing that the majority…

Are lung metastases from historically “radioresistant” primary tumors also radioresistant? This retrospective study identified 114 patients who received mostly (91%)…

Sometimes it feels like there’s a double standard when it comes to radiation and other forms of cancer therapy such…

Evaluating surveillance CT scans and reassuring other providers after lung SABR can be frustrating to say the least. That’s because…

We’ve seen a phase 2 trial that showed excellent local control with SABR for sarcoma lung mets. In this retrospective…